News & Insights

Using predictive analytics to bolster medication adherence

When a patient doesn’t take their medication as prescribed, the impact goes beyond the individual. Medication nonadherence is a $300 billion issue, according to Healthcare Finance, and to address the problem, some health care players are beginning to deploy traditional adherence methods coupled with predictive analytics. What is medication adherence? Medication adherence is not limited […]

New Hampshire Board of Medicine Recognizes Venebio Opioid Advisor™ as Approved Prescription Opioid Risk Assessment Tool

RICHMOND, Va. – January 31, 2018 – The New Hampshire Board of Medicine has approved Venebio Opioid Advisor™ (VOA™) as one of the state’s official risk assessment tools for opioid prescribing. New Hampshire state law requires that any opioid risk assessment tool be approved by the New Hampshire Board of Medicine. The 11-person board approved VOA […]

How Many Scientists Does It Take to Name a Company?

We frequently get asked how we came up with the name of our company – Venebio.  Here’s the story. Not surprisingly, when you present a question to a group of scientists, you can expect them to look at it from every possible angle to find the definitive answer. For a company specializing in life sciences […]

Study Revealing Highest Risk Profiles for Prescription Opioid Overdose to be Published in Next Issue of Pain Medicine

Comprehensive analysis of U.S. prescription opioid users and overdose cases further supports personalized approach to prescription of opioids. RICHMOND, Va. – DECEMBER 21, 2017 – Individuals suffering from a substance use disorder (SUD) or depression are among those at highest risk for a serious prescription opioid overdose, according to a study slated for the January […]

Pain Medicine to Publish Study Validating Venebio Opioid Advisor’s Ability to Identify Patients at Risk of Prescription Opioid Overdose

Venebio Opioid Advisor is the only validated tool to predict the likelihood of a life-threatening opioid overdose with 90-percent accuracy. RICHMOND, Va. – December 21, 2017 – A study validating the strong performance of Venebio Group’s risk-screening tool for prescription opioid overdose — Venebio Opioid Advisor™ (VOA™) — is slated to be published in the […]

GAO Report: CMS Needs to Broaden Opioid Efforts to Identify and Address Those at Risk for Serious Harm

The Centers for Medicare and Medicaid Services (CMS) have focused for years on identifying opioid-treated beneficiaries at risk for serious harm such as overdose or addiction. Their approach has concentrated on patients prescribed high daily doses of opioids who also have indicators of opioid misuse or abuse, such as ‘doctor shopping’ (multiple prescribers and pharmacies). […]

Eight Steps of Quality Control in Scientific Writing

A smooth and effective quality control process involves establishing guidelines at the beginning of the research and writing process, and then ensuring accuracy and consistency from start to finish. Here are eight steps towards good quality control in scientific writing. 1. Track your data We’ve all heard time and time again to make sure your […]

Venebio to Demo Opioid Overdose Risk-Screening Tool, Venebio Opioid Advisor, at Health 2.0

Demo to be part of breakout session, “Platforms for Provider Decision Support,” on Monday, October 2, at 11:30 a.m. in Grand Ballroom D Venebio Group, a leader in personalized risk prediction algorithms, will be demoing its risk-screening tool for prescription opioid overdose, Venebio Opioid Advisor™ (VOA™), at the 11th annual Health 2.0 conference in Santa […]

5 differences between a systematic review and other types of literature review

There are many types of reviews of the medical and public health evidence, each with its own benefits and challenges. In this blog post, we detail five key differences between a systematic review and other types of reviews, including narrative and comprehensive reviews. First, we must define some terms. “Literature review” is a general term […]

Second Health Plan to Implement Venebio’s Opioid Overdose Risk-Screening Tool

Recently published white paper estimates tool could result in 15% fewer prescription opioid overdoses RICHMOND, Va. (September 22, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that Amida Care, a New York-based health plan provider, has implemented Venebio Opioid Advisor™ (VOA™), the company’s risk-screening tool for prescription opioid overdose. Amida […]